Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Cell|November 20, 2025
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemiaAlexander C Lewis, Emily Gruber, Rheana Franich, et al.
Nature Structural & Molecular Biology|June 14, 2016
Functional interdependence of BRD4 and DOT1L in MLL leukemiaOmer Gilan, Enid Y N Lam, Isabelle Becher, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cell Reports|June 2, 2026
An orally active dual CBP/p300 degrader targets core dependencies of multiple myelomaPraveen Kumar Tiwari, Bomin Ku, Drew A Harrison, et al.
Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.
Blood Neoplasia|June 24, 2025
Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapyJoshua W D Tobin, Venkata A Chikatamarla, Marko Matic, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in NeuroblastomaLin Xiao, Klaartje Somers, Jayne Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting ThrombocytopeniaSrividya B Balachander, Steven W Criscione, Kate F Byth, et al.
Pageof 25